文献速递关节外科

地塞米松对糖尿病患者初次全关节置换术后血糖控制的影响:一项回顾性队列研究

Effects of Dexamethasone on Postoperative Glycemic Control in Diabetic Patients Following Primary Total Joint Arthroplasty: A Retrospective Cohort Study.
PubMed 文献 · J Arthroplasty · 2023-04-10

该项回顾性队列研究纳入2020年5月6日至2021年12月17日期间接受初次全髋关节置换术的523例糖尿病患者和接受初次全膝关节置换术的953例糖尿病患者,比较围手术期接受1剂地塞米松10 mg静脉注射与接受2剂的患者。结果显示,2剂组在全膝关节置换术后24至60小时的平均和最大血糖水平显著高于1剂组,在全髋关节置换术后24至36小时的平均血糖水平显著高于1剂组;但2剂组在全膝关节置换术后24至72小时的阿片类药物消耗量和总消耗量显著低于1剂组,两组的语言评定量表疼痛评分在各时间区间均无差异。作者认为,第二剂围手术期地塞米松与术后血糖水平升高相关,但观察到的血糖控制影响可能不会超过第二剂糖皮质激素的临床获益。

要点

  • 在全膝关节置换术糖尿病患者中,2剂地塞米松组术后24至60小时的平均和最大血糖水平显著高于1剂组。
  • 在全髋关节置换术糖尿病患者中,2剂地塞米松组术后24至36小时的平均血糖水平显著高于1剂组。
  • 在全膝关节置换术糖尿病患者中,2剂地塞米松组术后24至72小时及总的阿片类药物消耗量显著低于1剂组,疼痛评分无差异。

核心结论

  • 作者认为,第二剂围手术期地塞米松与术后血糖水平升高相关,但观察到的血糖控制影响可能不会超过第二剂糖皮质激素的临床获益。

研究设计与样本

  • 回顾性队列研究,纳入2020年5月6日至2021年12月17日期间接受初次择期全髋关节置换术的523例糖尿病患者和接受初次择期全膝关节置换术的953例糖尿病患者。
  • 比较围手术期接受1剂地塞米松10 mg静脉注射(1D组)与接受2剂(2D组)的糖尿病患者。

主要发现

  • 在全膝关节置换术队列中,2D组术后24至60小时的平均和最大血糖水平显著高于1D组。
  • 在全髋关节置换术队列中,2D组术后24至36小时的平均血糖水平显著高于1D组。
  • 在全膝关节置换术队列中,2D组术后24至72小时的阿片类药物消耗量及总消耗量显著低于1D组。
  • 在全膝关节置换术和全髋关节置换术队列中,两组的语言评定量表疼痛评分在各时间区间均无差异。

关键数值与推荐

  • 围手术期地塞米松给药方案:1剂为10 mg静脉注射,2剂为在1剂基础上追加第二剂。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Concerns regarding the effects of dexamethasone on diabetics' glucose control have stymied its use following total joint arthroplasty. This study aimed to evaluate the effects of 2 intravenous (IV) perioperative doses of dexamethasone on glucose levels, pain scores, and inpatient opioid consumption following total joint arthroplasty in diabetic patients. METHODS: A retrospective review of 523 diabetic patients who underwent primary elective THA and 953 diabetic patients who underwent primary elective total knee arthroplasty (TKA) between May 6, 2020, and December 17, 2021 was conducted. Patients who received 1 dose (1D) of perioperative dexamethasone 10 mg IV were compared to patients who received 2 doses (2D). Primary outcomes included postoperative glucose levels, opioid consumption as morphine milligram equivalences, postoperative pain as Verbal Rating Scale pain scores, and postoperative complications. RESULTS: The 2D TKA cohort had significantly greater average and maximum blood glucose levels from 24 to 60 hours compared to the 1D TKA cohort. The 2D THA cohort had significantly greater average blood glucose levels at 24 to 36 hours compared to the 1D THA cohort. However, the 2D TKA group had significantly reduced opioid consumption from 24 to 72 hours and reduced total consumption compared to the 1D TKA group. Verbal Rating Scale pain scores did not differ between cohorts for both TKA and THA at any interval. CONCLUSION: Administration of a second perioperative dose of dexamethasone was associated with increased postoperative blood glucose levels. However, the observed effect on glucose control may not outweigh the clinical benefits of a second perioperative dose of glucocorticoids.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Arraut J, Thomas J, Oakley CT, et al. Effects of Dexamethasone on Postoperative Glycemic Control in Diabetic Patients Following Primary Total Joint Arthroplasty: A Retrospective Cohort Study. J Arthroplasty. 2023. PMID: 37040822. doi:10.1016/j.arth.2023.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。